Research & Literature

Catastrophic APS in the context of other thrombotic microangiopathies.

Rodríguez-Pintó I, Espinosa G, Cervera R

Current rheumatology reports 2015; (17(1)):482 doi:10.1007/s11926-014-0482-z.

A therapeutic challenge: catastrophic anti-phospholipid syndrome with diffuse alveolar haemorrhage.

Martis N, Blanchouin E, Lazdunski R, et al.

Immunologic research 2015; (62(2)):222-4 doi:10.1007/s12026-015-8649-x.

Atypical Subacute Recurrence of Catastrophic Antiphospholipid Syndrome in a Japanese Female Patient.

Horikoshi M, Inokuma S, Matsubara E, et al.

Internal medicine (Tokyo, Japan) 2015; (54(22)):2923-7 doi:10.2169/internalmedicine.54.5150.

Treatment of catastrophic antiphospholipid syndrome.

Kazzaz NM, McCune WJ, Knight JS

Current opinion in rheumatology 2016; (28(3)):218-27 doi:10.1097/BOR.0000000000000269.

Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed.

Hoayek JG, Moussa HN, Rehman HA, et al.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2016; (29(24)):3950-5 doi:10.3109/14767058.2016.1160047.

[2016 review on catastrophic antiphospholipid syndrome].

Costedoat-Chalumeau N, Coutte L, Le Guern V, et al.

Presse medicale (Paris, France : 1983) 2016; (45(12 Pt 1)):1084-1092 doi:10.1016/j.lpm.2016.07.023.

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry.

Rodríguez-Pintó I, Moitinho M, Santacreu I, et al.

Autoimmunity reviews 2016; (15(12)):1120-1124 doi:10.1016/j.autrev.2016.09.010.

Catastrophic antiphospholipid antibody syndrome presenting as acute vascular occlusion in a young female patient.

Alonso JV, Del Pozo FJF, Álvarez MV, et al.

Reumatologia clinica 2018; (14(1)):49-52 doi:10.1016/j.reuma.2016.09.002.

Perioperative management of patients with antiphospholipid syndrome: a single-center experience.

Atisha-Fregoso Y, Espejo-Poox E, Carrillo-Maravilla E, et al.

Rheumatology international 2017; (37(7)):1159-1164 doi:10.1007/s00296-017-3727-0.

The catastrophic antiphospholipid syndrome in children.

Go EJL, O'Neil KM

Current opinion in rheumatology 2017; (29(5)):516-522 doi:10.1097/BOR.0000000000000426.

Diagnosis and management of the antiphospholipid syndrome.

Chaturvedi S, McCrae KR

Blood reviews 2017; (31(6)):406-417 doi:10.1016/j.blre.2017.07.006.

Thrombocytopenia in high-risk patients with antiphospholipid syndrome.

Pontara E, Banzato A, Bison E, et al.

Journal of thrombosis and haemostasis : JTH 2018; (16(3)):529-532 doi:10.1111/jth.13947.

Clinical Report of Probable Catastrophic Antiphospholipid Syndrome in Pregnancy.

Hakman E, Mikhael S

Case reports in obstetrics and gynecology 2018; (2018()):4176456 doi:10.1155/2018/4176456.

The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement.

Rymarz A, Niemczyk S

BMC nephrology 2018; (19(1)):132 doi:10.1186/s12882-018-0928-z.

Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.

Ruffatti A, De Silvestro G, Marson P, et al.

Journal of autoimmunity 2018; (93()):124-130 doi:10.1016/j.jaut.2018.07.001.

[Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].

Gu JY, Lu C, Shi H, Yang CD

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2018; (50(6)):1033-1038.

Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome.

Vreede AP, Bockenstedt PL, McCune WJ, Knight JS

Current opinion in rheumatology 2019; (31(3)):231-240 doi:10.1097/BOR.0000000000000595.

EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, et al.

Annals of the rheumatic diseases 2019; (78(10)):1296-1304 doi:10.1136/annrheumdis-2019-215213.

CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.

Pineton de Chambrun M, Larcher R, Pène F, et al.

Journal of autoimmunity 2019; (103()):102292 doi:10.1016/j.jaut.2019.06.003.

[What are the indications for rescue procedures? : Systemic rheumatic diseases in the intensive care unit].

Hellmich B, Löffler C

Zeitschrift fur Rheumatologie 2019; (78(10)):955-966 doi:10.1007/s00393-019-00687-0.

In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission.

Pineton de Chambrun M, Larcher R, Pène F, et al.

Chest 2020; (157(5)):1158-1166 doi:10.1016/j.chest.2019.11.010.

Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban.

Stammler R, Legendre P, Cacoub P, et al.

Lupus 2020; (29(7)):787-790 doi:10.1177/0961203320914363.

Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchange.

James TE, Martin LJ, Warkentin TE, Crowther MA

Platelets 2021; (32(6)):828-831 doi:10.1080/09537104.2020.1802414.

Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.

Fakhouri F, Scully M, Provôt F, et al.

Blood 2020; (136(19)):2103-2117 doi:10.1182/blood.2020005221.

Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus: a case-based review.

Garcia-Diaz J, Escudero-Salamanca M, Alvarez-Santana R, Espinola-Zavaleta N

Future cardiology 2021; (17(6)):985-990 doi:10.2217/fca-2020-0145.

Case of catastrophic antiphospholipid syndrome presenting as neuroretinitis and vaso-occlusive retinopathy.

In Yun Y, Kim JH, Lim SH, et al.

BMC ophthalmology 2020; (20(1)):482 doi:10.1186/s12886-020-01755-9.

Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.

Cohen H, Efthymiou M, Devreese KMJ

Journal of thrombosis and haemostasis : JTH 2021; (19(4)):892-908 doi:10.1111/jth.15217.

Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature.

Favaloro EJ, Henry BM, Lippi G

Seminars in thrombosis and hemostasis 2022; (48(1)):55-71 doi:10.1055/s-0041-1729856.

Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines.

Pastori D, Menichelli D, Cammisotto V, Pignatelli P

Frontiers in cardiovascular medicine 2021; (8()):715878 doi:10.3389/fcvm.2021.715878.

A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding.

Lim W, Kaur A, Munoh Kenne F, Shulimovich M

Cureus 2021; (13(8)):e17106 doi:10.7759/cureus.17106.

A Middle-Aged Woman Presented with Catastrophic Anti-phospholipid Syndrome in Nephrology Department of BSMMU.

Faroque MO, Islam SF, Hadiuzzaman KM, et al.

Mymensingh medical journal : MMJ 2022; (31(1)):267-271.

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry".

López-Benjume B, Rodríguez-Pintó I, Amigo MC, et al.

Autoimmunity reviews 2022; (21(4)):103055 doi:10.1016/j.autrev.2022.103055.

Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case.

Christiansen TK, Nilsson AC, Madsen GI, Voss A

Lupus 2022; (31(6)):754-758 doi:10.1177/09612033221093496.

Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome.

Mustafa R

Current neurology and neuroscience reports 2022; (22(10)):589-600 doi:10.1007/s11910-022-01228-0.

Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.

Dupré A, Morel N, Yelnik C, et al.

JAMA dermatology 2023; (159(1)):62-67 doi:10.1001/jamadermatol.2022.5221.

Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.

Stammler R, Nguyen Y, Yelnik C, et al.

Journal of thrombosis and haemostasis : JTH 2023; (21(5)):1258-1265 doi:10.1016/j.jtha.2023.02.007.

Catastrophic antiphospholipid syndrome accompanied by complement regulatory gene mutation.

Pul S, Gökçe İ, Bodur ED, et al.

The Turkish journal of pediatrics 2023; (65(2)):330-337.

Catastrophic Antiphospholipid Syndrome: A Case Series.

Christopher N, Periaswamy G, Arunachalam VK, et al.

The Indian journal of radiology & imaging 2023; (33(2)):235-239 doi:10.1055/s-0042-1759857.

An Overview of Heparin Monitoring with the Anti-Xa Assay.

Dean CL

Methods in molecular biology (Clifton, N.J.) 2023; (2663()):343-353 doi:10.1007/978-1-0716-3175-1_22.

Therapeutic Plasma Exchange in Catastrophic Antiphospholipid Syndrome (CAPS): A Rare Case Report and Literature Review.

Bereanu AS, Pisaltu T, Bereanu R, et al.

In vivo (Athens, Greece) 2023; (37(4)):1914-1919 doi:10.21873/invivo.13286.

Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

Jacobs L, Wauters N, Lablad Y, et al.

Antibodies (Basel, Switzerland) 2024; (13(1)) doi:10.3390/antib13010021.

Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry".

Pons I, Jeréz A, Espinosa G, et al.

Seminars in arthritis and rheumatism 2024; (66()):152439 doi:10.1016/j.semarthrit.2024.152439.

Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?

Moyon Q, Mathian A, Papo M, et al.

Current rheumatology reports 2024; (26(7)):269-277 doi:10.1007/s11926-024-01148-7.

AngioJet thrombectomy with extracorporeal membrane oxygenation support for an acute large-scale pulmonary embolism with bilateral atrial thrombosis: a case report of catastrophic antiphospholipid syndrome.

Ji J, Jiang L, Wang W, et al.

Frontiers in cardiovascular medicine 2024; (11()):1409775 doi:10.3389/fcvm.2024.1409775.

Systemic Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke: A Case of Suspected Catastrophic Antiphospholipid Syndrome.

Makino R, Machida A, Nagano Y, et al.

Journal of neuroendovascular therapy 2024; (18(7)):197-202 doi:10.5797/jnet.cr.2024-0023.

Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients.

Azoulay LD, Frapard T, Larcher R, et al.

Clinical rheumatology 2024; (43(9)):2889-2898 doi:10.1007/s10067-024-07051-x.

Catastrophic antiphospholipid syndrome: Lessons from the "CAPS Registry".

Rodriguez-Pintó I, Espinosa G, Cervera R

Medicina clinica 2024; (163 Suppl 1()):S31-S35 doi:10.1016/j.medcli.2024.02.011.

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome.

Carrara C, Mataj B, Gastoldi S, et al.

Frontiers in immunology 2024; (15()):1460317 doi:10.3389/fimmu.2024.1460317.

Warfarin and heparin monitoring in antiphospholipid syndrome.

Mittal P, Sayar Z, Cohen H

Hematology. American Society of Hematology. Education Program 2024; (2024(1)):192-199 doi:10.1182/hematology.2024000547.

Catastrophic antiphospholipid syndrome: a CAPS-tivating hematologic disease.

Salter BM, Crowther MA

Hematology. American Society of Hematology. Education Program 2024; (2024(1)):214-221 doi:10.1182/hematology.2024000544.

Catastrophic antiphospholipid syndrome of pregnancy with acute massive cerebral infarction: A case report.

Hu X, Liu M

Medicine 2024; (103(50)):e40829 doi:10.1097/MD.0000000000040829.

Case Report: Catastrophic antiphospholipid syndrome in a pediatric patient after percutaneous treatment of aortic re-coarctation.

García Herrera IP, Canales Robredo C, Aboytes Zavala M, et al.

Frontiers in pediatrics 2024; (12()):1410400 doi:10.3389/fped.2024.1410400.

External Quality Assessment for Unfractionated Heparin Monitoring: An Update from Australasia/Asia-Pacific.

Favaloro EJ, Arunachalam S, Pasalic L

Seminars in thrombosis and hemostasis 2026; doi:10.1055/a-2779-0035.

Catastrophic Antiphospholipid Syndrome.

Gris JC, Chea M, Perez-Martin A

Seminars in thrombosis and hemostasis 2026; doi:10.1055/a-2765-9663.

Diffuse alveolar hemorrhage in antiphospholipid syndrome: Clinical presentation and prognosis.

Cariou PL, Pineton de Chambrun M, Ben Salem T, et al.

Respiratory medicine 2026; (254()):108735 doi:10.1016/j.rmed.2026.108735.

Catastrophic Antiphospholipid Syndrome: A Rare but Life-Threatening Thrombotic Storm-A Case Report and Literature Review.

Morecroft R, Phillipps J, Majithia V, Mumtaz S

Case reports in rheumatology 2026; (2026()):8852169 doi:10.1155/crrh/8852169.

Perioperative management of antithrombotic therapy in patients with thrombotic antiphospholipid syndrome.

Paquette M, Miranda S, Xu Y, et al.

Blood advances 2026; (10(9)):3218-3228 doi:10.1182/bloodadvances.2026019610.

Laboratory Monitoring Unfractionated Heparin Treatments: Unanswered Issues.

Toulon P

International journal of laboratory hematology 2026; doi:10.1111/ijlh.70195.

Concurrent Catastrophic Antiphospholipid Syndrome, Hemophagocytic Lymphohistiocytosis, and Myocarditis Leading to Multi-organ Failure in a Patient With Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

Chauhan S, Suleman M, Chan A

Cureus 2026; (18(9)):e116801 doi:10.7759/cureus.116801.